Occurrence and transferability of β-lactam resistance in Enterobacteriaceae isolated in Children's University Hospital in Bratislava

Folia Microbiologica

Volumn 46, Issue 4, 2001, Pages 339-344

  Bujdakova H ^a   Hanzen, J ^b   Jankovicova S ^a   Klimaokova J ^a   Moravcikova M ^a   Milosovic P ^b   Michalkova Papajova D ^a   Kallova J ^a   Jakab, A ^c   Kettner, M ^a  

^a Physics and Informatics   (Slovakia)

^b HPL spol s ro   (Slovakia)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE; CEFTAZIDIME;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CONJUGATION; DRUG EFFECT; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; ENZYMOLOGY; GENETICS; HUMAN; INFANT; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; NEWBORN; PLASMID; PRESCHOOL CHILD; SLOVAKIA; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; CEFTAZIDIME; CHILD, PRESCHOOL; CONJUGATION, GENETIC; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; INFANT; INFANT, NEWBORN; MICROBIAL SENSITIVITY TESTS; PLASMIDS; SLOVAKIA;

EID: 0035752054     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02815624     Document Type: Article

References (35)

1. ADAM A.: β-Lactam antibiotics: their role in management of infections in children. Pediatr.Infect.Dis.J. 17, S4-S7 (1998).
2. BABÁLOVÁ M., BLAHOVÁ J., LEŠICKÁ-HUPKOVÁ M., KRÁLIKOVÁ K., KRČMÉRY V. URGELOVÁ A., BANÍKOVÁ I.: Transferable resistance to cefotaxime and other antibiotics in nosocomial strains of Serratia marcescens, Proteus mirabilis and Enterobacter cloacae. Antiinfect.Drugs Chemother. 13, 177-178 (1995).
3. BAUERNFEIND A., SCHNEIDER I., JUNGWIRTH R., SAHLY H., ULLMAN U.: A novel type of AmpC β-lactamase, ACC-1, produced by a Klebsiella pneumoniae strain causing nosocomial pneumonia. Antimicrob.Agents Chemother. 43, 1924-1931 (1999).
4. BERMUDES H., JUDE F., CHAIBI E.B., ARPIN C., BEBEAR C., LABIA R., QUENTIN C.: Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derivated β-lactamase in a clinical isolate of Klebsiella oxytoca. Antimicrob.Agents Chemother. 43, 1657-1661 (1999).
5. BRADFORD P.A., URBAN C., MARIANO N., PROJAN S.J., RAHAL J.J., BUSH K.: Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the lost of an outer membrane protein. Antimicrob.Agents Chemother. 41, 563-569 (1997).
6. BUJDÁKOVÁ H., KLIMÁČKOVÁ J., ALLERBERGER F., MORAVČÍKOVÁ M., BAGOVÁ M., HANZEN J., MICHÁLKOVÁ-PAPAJOVÁ D., DIERICH M.P., KETTNER M.: Spectrum and transferability of β-lactam resistance in hospital strains of Enterobacter isolated in Bratislava and Innsbruck. Internat. J.Antimicrob.Agents 16, 31-36 (2000).
7. BUJDÁKOVÁ H., LAUŠOVÁ A., JANKOVIČOVÁ S., PRODINGER W.P., KALLOVÁ J., MILOŠOVIČ P., KETTNER M.: Study of β-lactam resistance in ceftazidime-resistant clinical isolates of Enterobacteriaceae. Internat.J.Antimicrob.Agents 10, 135-141 (1998).
8. BUSH K.: Is it important to identify extended-spectrum β-lactamase-producing isolates? Eur.J.Clin.Microbiol.Infect.Dis. 15, 361-364 (1996).
9. CHANAL C., SIROT D., ROMASYKO J.P., BRET L., SIROT J.: Survey of prevalence of extended spectrum β-lactamases among Enterobacteriaceae. J.Antimicrob.Chemother. 38, 127-132 (1996).
10. GARAU J.: Clinical strategies for serious infections: a European perspective. Diagn.Microbiol.Infect.Dis. 31, 397-404 (1998).
11. GAZOULI M., TZOUVELEKIS L.S., VATOPOULOS A.C., TZELEPI E.: Transferable class C β-lactamases in Escherichia coli strains isolated in Greek hospitals and characterization of two enzyme variants (LAT-3 and LAT-4) closely related to Citrobacter freundii AmpC β-lactamase. J.Antimicrob.Chemother. 42, 419-425 (1998).
12. GIRAMONTI K.M., JOHNSON-ROBINS L.A., WEATHERWAX D.L., MORGAN M.J.: Reevaluting practice changes: return to standard precautions after an outbreak of multidrug-resistant Klebsiella oxytoca. J.Nurs.Care Qual. 14, 57-62 (2000).
13. HUBER T.W., THOMAS J.S.: Detection of resistance due to inducible β-lactamase in Enterobacter cloacae. J.Clin.Microbiol. 32, 481-486 (1994).
14. JACOBY G.A.: Genetics of extended-spectrum β-lactamases. Eur.J.Clin.Microbiol.Infect.Dis. 1, 2-11 (1994).
15. JARLIER V., NICOLAS M., FOURNIER G., PHILIPPON A.: Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev.Infect.Dis. 10, 867-878 (1998).
16. JENKS P.J., HU Y.M., DANIEL F., MENTAR S., LIVERMORE D.M.: Plasmid-mediated production of Class I (AmpC) β-lactamase by two Klebsiella pneumoniae isolates from UK. J.Antimicrob.Chemother. 35, 235-236 (1995).
17. LEBLEBICIOGLU H., NAS Y., EROGLU C., SUNBUL M., ESEN S., GUNAYDIN M.: Detection of extended spectrum β-lactamases in Escherichia coli and Klebsiella pneumoniae. J.Chemother. 11, 103-106 (1999).
18. LEIBOVICI L., PAUL M., POZNANSKI O., SAMRA Z., KONIGSBERGER H., PITLIK S.D.: Monotherapy versus β-lactam-aminoglycoside combination treatment for Gram-negative bacteremia: a prospective, observational study. Antimicrob.Agents Chemother. 41, 1127-1133 (1997).
19. LINDBERG F., NORMARK S.: Contribution of chromosomal β-lactamases to β-lactam resistance in Enterobacteria. Rev.Infect.Dis. 8, 292-304 (1986).
20. MANIATIS A.N., TROUGAKOS I.P., KATSANIS G., PALERMOS J., MANIATIS N.A., LEGAKIS N.J.: Changing patterns of bacterial nosocomial infections - a 9 year study in a general hospital. Chemotherapy 43, 69-76 (1997).
21. MARTINEZ-MARTINEZ L., PASCUAL A., HERNANDEZ-ALLES S., ALVAREZ-DIAZ D., SUAREZ A.I., TRAN J., BENEDI V.J., JACO-BY G.A.: Roles of β-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae. Antimicrob.Agents Chemother. 43, 1669-1673 (1999).
22. MEDEIROS A.A.: Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics. Clin.Infect.Dis. 24, S19-45 (1997).
23. NEUWIRTH C., LABIA R., SIEBOR E., PECHINOT A., MADEC S., CHAIBI E.B., KAZMIERCZAK A.: Characterization of TEM-56, a novel β-lactamase produced by Klebsiella pneumoniae clinical isolate. Antimicrob.Agents Chemother. 44, 453-455 (2000).
24. NEUWIRTH C., SIEBOR E., LOPEZ J., PECHINOT A., KAZMIERCZAK A.: Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended spectrum β-lactamase to other members of the family Enterobacteriaceae. J.Clin.Microbiol. 24, 76-79 (1994).
25. NICOLAS-CHANOINE M.H.: Inhibitor-resistant β-lactamases. J.Antimicrob.Chemother. 40, 1-3 (1997).
26. NUECH-INDERBINEN M.T., KAYSER F.H., HACHLER H.: Survey and molecular genetics of SHV β-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. Antimicrob.Agents Chemother. 41, 943-949 (1997).
27. PALUCHA A., MICKIEWICZ B., GNIADKOWSKI M.: Diversification of Escherichia coli expressing and SHV-type extended-spectrum β-lactamase (ESBL) during a hospital outbreak: emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins. Antimicrob.Agents Chemother. 43, 393-396 (1999).
28. PALUCHA A., MICKIEWICZ B., HRYNIEWICZ W., GNIADKOWSKI M.: Concurrent outbreaks of extended-spectrum β-lactamase-producing organisms of the family Enterobacteriaceae in Warsaw hospital. J.Antimicrob.Chemother. 44, 489-499 (1999).
29. PENA C., PUJOL M., ARDANUY C.: Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob.Agents Chemother. 42, 53-58 (1998).
30. PITHOUT J.D., SANDERS C.C., SANDERS W.E. Jr.: Antimicrobial resistance with focus on β-lactam resistance in Gram-negative bacilli. Am.J.Med. 103, 51-59 (1997).
31. SANCHEZ L., RUIZ N., LERANOZ S., VINAS M., PUIG M.: The role of outer membrane in Serratia marcescens intrinsic resistance to antibiotics. Microbiologia 13, 315-320 (1997).
32. SCHINDLER P., HUBER G.: Use of PADAC, a novel chomogenic β-lactamase substrate, for the detection of β-lactamase producing organisms and assay of β-lactamase inhibitors/inactivators, pp.169-176 in U. Brodbeck (Ed.): Enzyme Inhibitors. Springer-Verlag, Weinheim (Germany) 1980.
33. SCHNUMACHER H., SKIBSTED U., HANSEN D.S., SCHEIBEL J.: Cefuroxime resistance in Klebsiella pneumoniae. Susceptibility to cefotaxime and ceftazidime despite production of ESBL. APMIS 105, 708-716 (1997).
34. TAKAHASHI S., NAGANO Y.: Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis. J.Clin. Microbiol. 20, 608-613 (1994).
35. WIEDEMAN B., DIETZ H.: Cefotaxime - unchanged antibacterial activity over years? Diagn.Microbiol.Infect.Dis. 22, 5-12 (1995).